Streetbeat News

Products Services

MGNX

MacroGenics shares are trading lower following the announcement of a presentation of clinical data from the TAMARACK Phase 2 study of vobramitamab duocarmazine at the upcoming European Society for Medical Oncology Congress 2024.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 9:04 pm

GIB

CGI Federal is set to acquire Aeyon to enhance its digital transformation and AI capabilities for the U.S. federal government. This acquisition is expected to strengthen CGI's relationships with national security clients. The transaction is anticipated to close in Q4 FY 2024, with terms not disclosed.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 9:00 pm

PEPG

PepGen shares are trading lower after the company announced clinical data from the first dose cohort of PGN-EDO51.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:59 pm

PRTS

CarParts.com expects FY24 net sales at the low end of the $600M - $625M range and a gross margin of 33%, plus or minus 100 basis points. The company has updated its pricing and marketing strategies to target more profitable customers, resulting in improved margins. Management anticipates sequential margin improvement in Q3 and aims for sustainable positive Adjusted EBITDA next year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:55 pm

ICFI

ICF has been awarded a nearly three-year, $17 million contract by the Los Angeles County Southern California Regional Energy Network to design and deliver residential energy efficiency programs.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:53 pm

VST

Vistra has received approval from the NRC to operate the Comanche Peak Nuclear Plant through 2053. The 2,400-megawatt plant will continue to provide reliable, zero-carbon electricity.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:49 pm

WGS

GeneDx (NASDAQ:WGS) has announced significant enhancements to its Whole Genome Sequencing (WGS) product, including faster turnaround times for Rapid Whole Genome Sequencing (rWGS), the addition of buccal sample types, and expanded repeat expansions. These improvements aim to accelerate diagnoses and improve patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:45 pm

EA

Electronic Arts Inc (NASDAQ:EA) reported Q1 financial results with net bookings of $1.26 billion, beating guidance but down from last year. The company highlighted strong performances from Madden NFL 24, FC Online, and FC Mobile. EA repurchased 2.8 million shares for $375 million. The company expects strong future performance with upcoming game releases.

Portfolio Pulse from Chris Katje

July 30, 2024 | 8:43 pm

AMD

INTC

NVDA

SOXX

SPY

AMD shares surged 4.8% in after-hours trading following a strong Q2 earnings report that beat expectations. The company reported increased revenue and earnings, driven by robust data center performance and accelerating AI business. AMD's Q3 guidance also topped expectations, projecting revenue of $6.7 billion. Rival Intel is set to report its earnings soon, while AMD's stock has lagged behind broader market indices year-to-date.

Portfolio Pulse from Shanthi Rexaline

July 30, 2024 | 8:37 pm

VIGL

Vigil Neuroscience, Inc. (NASDAQ: VIGL) presented clinical data on its small molecule TREM2 agonist program at the 2024 Alzheimer's Association International Conference. The data from the Phase 1 clinical trial of VG-3927 in healthy volunteers demonstrated proof-of-pharmacology, and new in vitro and in vivo data showed modulation of Alzheimer's disease pathophysiology.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:29 pm